Oxalic Acid

Oxalic Acid

SCHEMBL5874777

O=C(O)C(=O)O.c1ccncc1.c1ccncc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 4/20 0.64
TSHR P16473 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
KMT2A Q03164 3/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 3/20 0.40
APP P05067 1/20 0.40
GAA P10253 1/20 0.40
HCAR3 P49019 1/20 0.40
HCAR2 Q8TDS4 1/20 0.40
PLOD2 O00469 2/20 0.37
TAAR1 Q96RJ0 1/20 0.37
PLOD3 O60568 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
PLOD1 Q02809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL4224676 1.00 NAPRT (0.64) NAPRTTSHRTDP1KMT2AMEN1
Oxalic Acid SCHEMBL28045246 0.97 NAPRT (0.60) NAPRTTSHRTDP1KMT2AMEN1
Oxalic Acid SCHEMBL28045245 0.97 NAPRT (0.60) NAPRTTSHRTDP1KMT2AMEN1
Pyridine SCHEMBL5278800 0.89 NAPRT (0.69) NAPRTTSHRTDP1KMT2AMEN1
Pyridine SCHEMBL910099 0.89 NAPRT (0.69) NAPRTTSHRTDP1KMT2AMEN1
Pyridine SCHEMBL5875149 0.89 NAPRT (0.69) NAPRTTSHRTDP1KMT2AMEN1
Pyridine SCHEMBL11080572 0.86 NAPRT (0.64) NAPRTTSHRTDP1KMT2AMEN1
Pyridine SCHEMBL28075136 0.86 NAPRT (0.64) NAPRTTSHRTDP1KMT2AMEN1
Pyridine SCHEMBL27638908 0.86 NAPRT (0.64) NAPRTTSHRTDP1KMT2AMEN1
Pyridine SCHEMBL28167155 0.86 NAPRT (0.64) NAPRTTSHRTDP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104254535-B Substituted pyrazolo [1,5 a] pyridine, its prepare and be used as the application of medicine 埃斯蒂文博士实验室股份有限公司 2017-07-14 CN claimed
CN-1072602-A Improve the enhanced dermal osmosis system of the local conveying of medicine RICHARDSON VICKS INC (US) 1993-06-02 CN claimed
CN-104387372-B Oxo azetidine derivatives, preparation method and its purposes in human medical and cosmetics 盖尔德马研究及发展公司 2018-06-26 CN disclosed
CN-104254535-B Substituted pyrazolo [1,5 a] pyridine, its prepare and be used as the application of medicine 埃斯蒂文博士实验室股份有限公司 2017-07-14 CN disclosed
CN-101260523-A Petroleum natural gas pipeline corrosion inhibitor prepared by waste grease and method thereof CHENGDU DUZHIJIE SCIENCE AND T (CN) 2008-09-10 CN disclosed
CN-101260523-A Petroleum natural gas pipeline corrosion inhibitor prepared by waste grease and method thereof CHENGDU DUZHIJIE SCIENCE AND T (CN) 2008-09-10 CN disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed
CN-1087936-C Antipsychotic method NOVO NORDISK AS (DK) 2002-07-24 CN disclosed
CN-1026588-C 1-alkyl substituted benzimidazole derivatives, process for preparing same and pharmaceutical composition containing same JANSSEN PHARMACEUTICA NV (BE) 1994-11-16 CN disclosed
CN-1020906-C PROCESS FOR PREPARATION OF 2-(HETEROCYCLYLALKYL) IMIDAZOPYRIDINES COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 1993-05-26 CN disclosed
CN-1030587-A 2-(Heterocyclylalkyl) imidazopyridine JANSSEN PHARMACEUTICA NV (BE) 1989-01-25 CN disclosed
CN-88101286-A 1-alkyl substituted benzimidazole derivatives, process for preparing same and pharmaceutical composition containing same 1988-09-28 CN disclosed